Audit

at
Categories
Tags

The accreditation process seeks to help organizations identify and resolve problems and to inspire them to improve the safety and quality of care and services provided. The process focuses on systems critical to the safety and the quality of care, treatment, and services.

Assume the role of director of accreditation. You will review and analyze the materials (e.g., records, previous audit, trends, e-mails) provided in the case study to prepare for the audit. You will need to look across all departments and examine trends and patient care issues to determine readiness.

A. Facilitate an organization’s continuous accreditation compliance process as you determine the readiness for the accreditation audit of the healthcare facility in the attached Accreditation Audit Case Study – Task 4 Artifacts by doing the following:
1. Discuss the current compliance status of the healthcare facility.
2. Discuss any trends evident in the Accreditation Audit Case Study – Task 4 Artifacts that may cause the organization to not be compliant with the Joint Commission standards for patient care.
3. Review the performance improvement standard regarding staffing in the healthcare facility’s patient care unit by doing the following:
a. Analyze the data to determine the staffing patterns of the patient care unit.
b. Develop a staffing plan to minimize the number of falls in the patient care unit.

Sample Solution

The medication discharge from the pH-delicate nanoparticles follows certain systems which include:

1-Drug burst discharges when the nanoparticle transporters disintegrate at explicit pH conditions:

They generally showed burst discharge profiles in light of the disintegration characters of the transporters; sedate discharge from customary nanoparticles was for the most part by dispersion. For pH-touchy nanoparticles, at low pH, the nanoparticles arranged from polycarboxylic corrosive were strong grid exemplifying medication, little medication discharged. As they arrive at the small digestive system, the pH changes from acidic to impartial (6–7.4), carboxylic corrosive gatherings deprotonated, the direct polymers broke down and medications discharged quickly.

2-Drug discharges when the polymers swell at explicit pH conditions:

Another explanation behind medication discharge from nanoparticles was the expanding of the materials [96].

At low pH, the polymers, especially cross-connected polymers, have a minimized structure, which significantly diminished the porosity of the grid. This caused a more slow arrival of medication because of the more prominent obstruction for dispersion of the medication out of the nanogel. In any case, at higher pH, the nanogel particles were in a swollen state with a higher porosity that supported the arrival of the medication due to the decrease in dissemination obstruction.

3-The medication discharges because of both polymer disintegration and expanding:

There was dark limit between tranquilize disintegration and expanding for the bearers. Some nanoparticle frameworks may discharge sedate through both the components. Li et al., 2006 [97] examined the arrival of insulin from chitosan–Eudragit L100-55 nanoparticles in vitro. The outcomes suggested that at low pH, the nanoparticles were secured by Eudragit L100-55, little water penetrated into the particles and when the pH esteem was raised to 5.8, Eudragit L100-55 disintegrated and water penetra

This question has been answered.

Get Answer